Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (121-130 of 299) with videos related to

Pageof 30
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Peripheral nerve entrapment: an unusual adverse event with high-dose interleukin-2 therapyS S Sikora, M E Samsonov, K A Dookeran, et al.
Transplantation|January 12, 1999
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsivenessT Takayama, Y Nishioka, L Lu, et al.
The Cancer Journal From Scientific American|July 1, 1995
Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usageM J Maeurer, S Hurd, D M Martin, et al.
Surgery|September 1, 1987
Limb-sparing surgery for soft tissue sarcomas: wound related morbidity in patients undergoing wide local excisionJ M Skibber, M T Lotze, C A Seipp, et al.
Biochemical and Biophysical Research Communications|October 6, 2001
Mitochondrial lipid alterations during Fas- and radiation-induced apoptosisC M Matsko, O C Hunter, H Rabinowich, et al.
Blood|March 15, 1992
Effects of in vivo administration of interleukin-2 (IL-2) and IL-4, alone and in combination, on ex vivo human basophil histamine releaseM V White, Y Igarashi, B E Emery, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transitionK Martincic, R Campbell, G Edwalds-Gilbert, et al.
Cancer Research|November 1, 1981
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factorM T Lotze, E A Grimm, A Mazumder, et al.
Cancer Research|September 15, 2000
Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cellsF Tanaka, W Hashimoto, H Okamura, et al.
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 balance in cancer, transplantation and pregnancyM R Shurin, L Lu, P Kalinski, et al.
Pageof 30

Showing results (121-130 of 299) with videos related to

Sort By:
Pageof 30
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Peripheral nerve entrapment: an unusual adverse event with high-dose interleukin-2 therapyS S Sikora, M E Samsonov, K A Dookeran, et al.
Transplantation|January 12, 1999
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsivenessT Takayama, Y Nishioka, L Lu, et al.
The Cancer Journal From Scientific American|July 1, 1995
Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usageM J Maeurer, S Hurd, D M Martin, et al.
Surgery|September 1, 1987
Limb-sparing surgery for soft tissue sarcomas: wound related morbidity in patients undergoing wide local excisionJ M Skibber, M T Lotze, C A Seipp, et al.
Biochemical and Biophysical Research Communications|October 6, 2001
Mitochondrial lipid alterations during Fas- and radiation-induced apoptosisC M Matsko, O C Hunter, H Rabinowich, et al.
Blood|March 15, 1992
Effects of in vivo administration of interleukin-2 (IL-2) and IL-4, alone and in combination, on ex vivo human basophil histamine releaseM V White, Y Igarashi, B E Emery, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transitionK Martincic, R Campbell, G Edwalds-Gilbert, et al.
Cancer Research|November 1, 1981
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factorM T Lotze, E A Grimm, A Mazumder, et al.
Cancer Research|September 15, 2000
Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cellsF Tanaka, W Hashimoto, H Okamura, et al.
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 balance in cancer, transplantation and pregnancyM R Shurin, L Lu, P Kalinski, et al.
Pageof 30